Tianjin Lisheng Pharmaceutical (002393.SZ) announced that the company has received a "Drug Registration Certificate" (Batch No.: 2024S01229) issued by the National Medical Products Administration for the slow release tablet of Indapamide...
Lisheng Pharmaceutical (002393.SZ) announced that the company has received a "Drug Registration Certificate" (Batch No.: 2024S01229) issued by the National Medical Products Administration for the 1.5mg slow release tablet of Indapamide, which has been granted permission for sale. Indapamide is used to treat primary hypertension in adults.